August 29th, 2022 (Earnings Report)Dear Reader,Our scanners just identified several healthtech stocks that are expected to release earnings starting today, September 25th, 2022.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Clinuvel Pharmaceuticals Limited
Symbol: CLVLF
Recent Price: $12.01
Average Analyst Price Target: $16.73 (39.30%)
Market Cap: $603.45M
Last Year's EPS:
Consensus EPS Forecast: n/a
Expected Earnings Date: n/a
Recent Analyst Action: Melissa Benson, analyst at Wilsons, reiterates coverage on Clinuvel Pharmaceuticals Limited (CLVLF) in the Healthcare sector with a Buy rating and a price target of $ 16.73 (1 month ago).
TipRanks.com also reports that Clinuvel Pharmaceuticals Limited currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.73 . The target pricing ranges from a high forecast of $16.73 down to a low forecast of $16.73. Clinuvel Pharmaceuticals Limited (CLVLF)’s last closing price was $12.01 which would put the average price target at 39.30% upside.Here are 3rd party ratings for CLVLF:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: sell
- Zacks.com: n/a
--------------------------------------------------------------------------
Cooper Co
Symbol: COO
Recent Price: $291.3
Average Analyst Price Target: $401.43 (37.81%)
Market Cap: $14.63B
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Matthew Mishan, analyst at KeyBanc, reiterates coverage on Cooper Co (COO) in the Healthcare sector with a Hold rating and a price target of n/a (22 hours ago).
TipRanks.com also reports that Cooper Co currently has 10 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $401.43 . The target pricing ranges from a high forecast of $470.00 down to a low forecast of $360.00. Cooper Co (COO)’s last closing price was $291.3 which would put the average price target at 37.81% upside.Here are 3rd party ratings for COO:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 35% (163 out of 252)
--------------------------------------------------------------------------
Opthea Limited
Symbol: CKDXF
Recent Price: $0.82
Average Analyst Price Target: $1.78 (117.07%)
Market Cap: $319.36M
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Chris Cooper, analyst at Goldman Sachs, reiterates coverage on Opthea Limited (CKDXF) in the Healthcare sector with a Buy rating and a price target of $ 1.78 (2 months ago).
TipRanks.com also reports that Opthea Limited currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $1.78 . The target pricing ranges from a high forecast of $1.78 down to a low forecast of $1.78. Opthea Limited (CKDXF)’s last closing price was $0.82 which would put the average price target at 117.07% upside.Here are 3rd party ratings for CKDXF:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: n/a
- Zacks.com: n/a
--------------------------------------------------------------------------
Aytu BioScience
Symbol: AYTU
Recent Price: $0.233
Average Analyst Price Target: n/a (2475.11%)
Market Cap: $16.20M
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on Aytu BioScience (AYTU) in the Healthcare sector with a Buy rating and a price target of $ 6 (1 month ago).
TipRanks.com also reports that Aytu BioScience currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00 . The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. Aytu BioScience (AYTU)’s last closing price was $0.233 which would put the average price target at 2475.11% upside.Here are 3rd party ratings for AYTU:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 27% (69 out of 252)
--------------------------------------------------------------------------
MEI Pharma
Symbol: MEIP
Recent Price: $0.528
Average Analyst Price Target: $15.00 (2738.76%)
Market Cap: $70.77M
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Leah R., analyst at Brookline Capital Markets, reiterates coverage on MEI Pharma (MEIP) in the Healthcare sector with a Buy rating and a price target of $ 15 (1 month ago).
TipRanks.com also reports that MEI Pharma currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.00 . The target pricing ranges from a high forecast of $15.00 down to a low forecast of $15.00. MEI Pharma (MEIP)’s last closing price was $0.528 which would put the average price target at 2738.76% upside.Here are 3rd party ratings for MEIP:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 31% (78 out of 252)
--------------------------------------------------------------------------
Patterson Companies
Symbol: PDCO
Recent Price: $28.68
Average Analyst Price Target: $37.75 (31.62%)
Market Cap: $2.78B
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Jeff Johnson, analyst at Robert W. Baird, reiterates coverage on Patterson Companies (PDCO) in the Healthcare sector with a Hold rating and a price target of $ 35 (1 month ago).
TipRanks.com also reports that Patterson Companies currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $37.75 . The target pricing ranges from a high forecast of $42.00 down to a low forecast of $35.00. Patterson Companies (PDCO)’s last closing price was $28.68 which would put the average price target at 31.62% upside.Here are 3rd party ratings for PDCO:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Bottom 35% (163 out of 252)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
